Library Home | Reset filters
Select one or more filter options and click search below.
Jessica A. Schmitt; Ambika P. Ashraf; David J. Becker (et al.)
There is concern that the growing incidence of pediatric type 2 diabetes (T2D) may have been further exacerbated by the COVID-19 pandemic. To examine whether trends in new-onset pediatric T2D—inclusive of patients requiring hospitalization and patients managed as outpatients—were impacted during the COVID-19 pandemic, and to compare patient characteristics prior to and during COVID-19. A retrospective single-center medical record review was conducted in a hospital which cares for 90% of Alabama’s pediatric T2D patients. Patients with new-onset T2D referred from March 2017 to March 2021 were included. Counts of patients presenting per month (“monthly rates”) were computed. Linear regression models were estimated for the full sample and stratified by Medicaid and non-Medicaid insurance status. Patient characteristics prior to vs during COVID-19 were compared.
Eduardo A. Oliveira; Robert H. Mak; Enrico A. Colosimo (et al.)
Diabetes has been recognized as a major comorbidity for COVID-19 severity in adults. This study aimed to characterize the clinical outcomes and risk factors for COVID-19-related death in a large cohort of hospitalized pediatric patients with diabetes. It performed an analysis of all pediatric patients with diabetes and COVID-19 registered in SIVEP-Gripe, a Brazilian nationwide surveillance database, between February 2020 and May 2021. The primary outcome was time to death, which was evaluated considering discharge as a competitive risk by using cumulative incidence function.
Abha Choudhary; Soumya Adhikari; Perrin C. White
The coronavirus disease-2019 (COVID-19) pandemic had widespread impacts on the lives of parents and children. This study determined how the pandemic affected Type 1 diabetes patients at a large urban pediatric teaching hospital. It compared patient characteristics, glycemic control, PHQ-9 depression screen, in person and virtual outpatient encounters, hospitalizations and continuous glucose monitor (CGM) utilization in approximately 1600 patients in 1 year periods preceding and following the local imposition of COVID-related restrictions on 3/15/2020 (“2019” and “2020” groups, respectively).
Barbara Piccini; Benedetta Pessina; Francesco Pezzoli (et al.)
Two vaccines against SARS-CoV-2 are approved by the World Health Organization (WHO) for minors aged 12 years and over. Currently, people with both type 1 diabetes (T1D) and type 2 diabetes (T2D) are prioritized for vaccination. This study aimed to evaluate possible glycemic control modification, insulin dose adjustment and adverse effects after COVID-19 vaccination in young T1D individuals, users of different technology levels. 39 T1D individuals, who received a whole vaccination cycle of either Moderna or Pfizer- BioNTech vaccines, were enrolled, 24 of whom using advanced hybrid closed loop systems (AHCLs) and 15 using intermittently scanned continuous glucose monitoring (isCGM). Symptoms after each dose and the following variables were considered: time in range 70-180 mg/dl (TIR), time in different glucose ranges, mean glucose levels, coefficient of variation (CV), total daily dose (TDD) and bolus proportion.
C. Carducci; N. Rapini; A. Deodati (et al.)
The Post-traumatic Stress Disorder (PTSD) is a group of persistent psychological and physiological symptoms due to a traumatic, severe, event. Only few studies focused on the effects of Covid-19 on psychosocial outcomes in children with Type 1 Diabetes (T1D) and their parents. The aim of this study was to evaluate the presence PTSD in parents of children with T1D during COVID-19 pandemic lockdown. In the period between March and May 2020 we submitted the “Impact of Event Scale – Revised” (IES-R) questionnaire to the parents of 34 children with Type 1 Diabetes, asking them to express their emotions about the ongoing Covid-19 pandemic.
Christine H. Wang; Marisa E. Hilliard; Samantha A. Carreon (et al.)
Yasmine Ibrahim Elhenawy; Khadiga Yehia Eltonbary
The COVID-19 pandemic and the consequences of lockdown significantly impacted glycemic control. This study aims to evaluate the impact of the pandemic and lockdown on glycemic control among Egyptian children and adolescents with type 1 diabetes. Cross-sectional study conducted through an online questionnaire. The participants were patients with type 1 diabetes and/or their caregivers
Hooi Peng Cheng; Jeanne Sze Lyn Wong; Nalini M. Selveindran (et al.)
Malaysia implemented nationwide lockdown from 18th March till 3rd May 2020 to mitigate the spread of coronavirus disease (COVID-19). This study aimed to examine the impact of the lockdown on glycaemic control and lifestyle changes in children and adolescents with type 1 (T1DM) and 2 diabetes mellitus (T2DM) aged less than 18 years old. In this cross-sectional study, interviews and a standardised questionnaire comparing lifestyle changes before and during the lockdown were performed in follow-up clinic visits after the lockdown. Anthropometry measurements and glycated haemoglobin (HbA1c) values were compared 3 months prior and after the lockdown.
Valeria Calcaterra; Dario Iafusco; Vittoria Carnevale Pellino (et al.)
This research explored the physical activity (PA) level and the variation in glycaemic control in children with type 1 diabetes (T1D) before and during the lockdown. Then, it proposed an online training program supported by sport-science specialists. Parents of children with T1D (<18 years) filled out an online survey. Anthropometric characteristics, PA, play, sport and sedentary time and the medical related outcomes were recorded. An adapted online program “Covidentary” was proposed through full-training (FT) and active breaks (AB) modality.
A. Lapolla; M. G. Dalfrà; S. Burlina
The recent availability of vaccines against COVID-19 has sparked national and international debate on the feasibility of administering them to pregnant and lactating women, given that these vaccines have not been tested to assess their safety and efficacy in such women. As concerns the risks of COVID-induced disease, published data show that pregnant women who develop COVID-19 have fewer symptoms than patients who are not pregnant, but they are more likely to need hospitalization in intensive care, and neonatal morbidity. Aim of the present perspective paper is to analyze the current literature regarding the use of the vaccine against COVID-19 infection, in terms of safety and protection, in high risk pregnant women as those affected by diabetes and obesity. Analysis of literature about vaccination against COVID-19 infection in pregnancy.
Hande Turan; Didem Kaya Güneş; Gürkan Tarçın (et al.)
Metabolic control in type 1 diabetes (T1D) depends on many factors such as eating habits, exercise and lifestyle. The objective of this study was to investigate how these factors were affected during the coronavirus disease 2019 (COVID-19) lockdown and impacted metabolic control in children with T1D. One hundred children with T1D were enrolled in the study. Anthropometric measurements, snack and meal frequency, carbohydrate consumption, HbA1c levels, and exercise patterns were recorded and compared before and after the lockdown. Subjects were divided into two subgroups — patients with decreased and patients with increased HbA1c levels after the lockdown — and comparisons of the same parameters were also made between these two subgroups.
Miriannette Gayoso; Whei Ying Lim; Madhuri S. Mulekar (et al.)
With the onset of the COVID-19 pandemic and state-mandated school closures in the spring of 2020, the management of type 1 diabetes in children underwent significant changes. The aim of this study was to assess the effect of stay-at-home orders on glycemic control in children. This study is a retrospective review of 238 children with type 1 and type 2 diabetes who were seen in the Pediatric Endocrinology Clinic at the University of South Alabama. Average Hemoglobin A1c (A1c) levels in the year prior to stay-at home orders (May 2019–April 2020) were compared with A1c values during the quarantine period (May 2020–July 2020) using a paired t-test. It also analyzed the change of A1c level with respect to sex, race, type of diabetes, type of insurance, and mode of insulin administration, using a 2-sample t-test.
Giuseppina Rosaria Umano; Anna Di Sessa; Stefano Guarino (et al.)
Caroline Wade; Leah Akinseye; Tachele Anderson (et al.)
UNICEF Innocenti's Children and COVID-19 Library is a database collecting research from around the world on COVID-19 and its impacts on children and adolescents.
Read the latest quarterly digest on children and disabilities.
The second digest discussed children and violence during the pandemic.
The first digest covers children and youth mental health under COVID-19.
Subscribe to updates on new research about COVID-19 & children
COVID-19 & Children: Rapid Research Response
Children need champions. Get involved, speak out, volunteer, or become a donor and give every child a fair chance to succeed.